Fast&Up Parent Fullife Secures ₹300 Crore Funding, Eyes Growth & Future IPO

• Fullife Healthcare, parent company of Fast&Up and Chicnutrix, raised ₹300 crore in Series D funding led by Elev8 Venture Partners.
• The fresh capital will be used to scale operations in manufacturing, product innovation, domestic distribution, and international markets.
• CEO Varun Khanna indicated an IPO is under consideration but not immediate, depending on market readiness and valuation of new-age consumer brands.
• Fullife aims for aggressive growth, projecting to reach ₹600 crore ARR in FY26 and maintaining a similar trajectory in FY27.
• Elev8 Venture Partners will provide strategic support beyond funding, including marketplace relationships, product direction, and IPO readiness.

Key Questions Answered

When might Fullife Healthcare consider its IPO?

Fullife Healthcare might consider an IPO in the next five years, potentially by 2030. CEO Varun Khanna indicated that an IPO is under consideration but not an immediate priority.

How will Fullife use its new ₹300 crore funding?

Fullife Healthcare will use its new ₹300 crore funding to accelerate growth for its brands, including Fast&Up and Chicnutrix.

What is the future outlook for new-age consumer brands?

New-age consumer brands are poised for growth by solving real problems, leveraging digital platforms, and prioritizing transparency and authenticity.